OPTIMAL HEMATOCRIT FOR CANINE SKELETAL MUSCLE DURING RHYTHMIC ISOTONIC EXERCISEGAEHTGENS P; KREUTZ F; ALBRECHT KH et al.1979; EUROP. J. APPL. PHYSIOL. OCCUP. PHYSIOL.; DEU; DA. 1979; VOL. 41; NO 1; PP. 27-39; BIBL. 36 REF.Article

FAHRAEUS EFFECT AND CELL SCREENING DURING TUBE FLOW OF HUMAN BLOOD. I. EFFECT OF VARIATION OF FLOW RATEGAEHTGENS F; ALBRECHT KH; KREUTZ F et al.1978; BIORHEOLOGY; GBR; DA. 1978; VOL. 15; NO 3-4; PP. 147-154; BIBL. 27 REF.Article

Novel bispecific immunoprobe for rapid and sensitive detection of prostate-specific antigenKREUTZ, F. T; SURESH, M. R.Clinical chemistry (Baltimore, Md.). 1997, Vol 43, Num 4, pp 649-656, issn 0009-9147Article

Efficient bispecific monoclonal antibody purification using gradient thiophilic affinity chromatographyKREUTZ, F. T; WISHART, D. S; SURESH, M. R et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 714, Num 2, pp 161-170, issn 1387-2273Article

Mimetic ligand-based affinity purification of immune complexes and immunoconjugatesDANZHU XU; LEVEUGLE, B; KREUTZ, F. T et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 706, Num 2, pp 217-229, issn 1387-2273Article

Considérations chronobiologiques pour la prise en charge des tumeurs de la tête et du cou chez l'homme = Chronobiological considerations for the management of human head and neck cancerFOCAN, C; FOCAN-HENRARD, D; KREUTZ, F et al.Pathologie et biologie. 2003, Vol 51, Num 4, pp 201-203, issn 0369-8114, 3 p.Article

Production of highly pure monoclonal antibodies without purification using a hollow fiber bioreactorKREUTZ, F. T; JAFARIN, A; BIGGS, D. F et al.Hybridoma. 1997, Vol 16, Num 5, pp 485-486, issn 0272-457XArticle

Production of murine/guinea pig and rat/guinea pig heterohybridomasJAMES, D. E; KREUTZ, F. T; BIGGS, D. F et al.Hybridoma. 1996, Vol 15, Num 5, pp 387-389, issn 0272-457XArticle

QU'ATTENDRE DE LA CHIMIOTHÉRAPIE DANS LE CANCER DE L'ESTOMAC EN 2008 ? = CHEMOTHERAPY FOR HUMAN GASTRIC CANCER : A REVIEWDEMOLIN, G; FOCAN, C; PLOMTEUX, O et al.RMLG. Revue médicale de Liège. 2008, Vol 63, Num 9, issn 0370-629X, 532-541 [10 p.]Article

Chimiothérapie adjuvante pour le cancer du colon de stades Dukes B2 et C comportant du 5-fluorouracile et de l'acide folinique, avec ou sans carboplatine. Faisabilité et comparaison d'une administration standard à une administration chronomodulée = Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveriesFOCAN, C; BURY, J; MATUS, G et al.Pathologie et biologie. 2005, Vol 53, Num 5, pp 281-284, issn 0369-8114, 4 p.Article